One submission wonder hits PBS

Posted 29 April 2025 AM

It’s just a matter of hours until Australians living with an aggressive type of blood cancer will have funded access to AbbVie’s Epkinly after Federal Treasurer Jim Chalmers announced the PBS listing during his Budget Speech.

As of 1 May the pegged blockbuster will be listed on the PBS for the treatment of patients with diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.

To see the whole article please log in.

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Email

Retype password

Not a member? Sign up here